TGFB1 and Alzheimer disease: Recently, microglial transcriptome analysis in AD patients and AD models has shown that inhibition of TGF-β signaling is associated with neurodegeneration, leading to a phenotype known as “MGnD” (microglial neurodegenerative phenotype).